Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in Active Sarcoidosis
NCT02134717Terminated
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of maraviroc in sarcoidosis. Primary endpoint: Total Cell Count and Differentials in Blood and Bronchoalveolar Lavage Fluid at 6 weeks. Started Jan 2014; status: terminated.
02
Drugs
maraviroc
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NCT02134717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134717.